Response: Re: Incidence of initial local therapy among men with lower-risk prostate cancer in the United States [2]

Journal of the National Cancer Institute

Volumn 98, Issue 24, 2006, Pages 1826-

  Miller, David C ^a   Gruber, Stephen B ^a,b   Hollenbeck, Brent K ^a   Montie, James E ^a   Wei, John T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; CANCER RISK; CANCER SURVIVAL; COST BENEFIT ANALYSIS; DECISION MAKING; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; INTERMETHOD COMPARISON; LETTER; LIFE EXPECTANCY; LOCAL THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 33845880621     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj491     Document Type: Letter

References (4)

1. Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer [see comment]. JAMA 2005;293:2095-101.
2. Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. New Engl J Med 2005;352:1977-84.
3. Cowen ME, Halasyamani LK, Kattan MW. Predicting life expectancy in men with clinically localized prostate cancer. J Urol 2006;175:99.
4. Kistler CE, Lewis CL, Amick HR, Bynum DL, Walter LC, Watson LC. Older adults' beliefs about physician-estimated life expectancy: A cross-sectional survey. BMC Fam Pract 2006;7:9.